We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $0.42 | — | — | $78.35M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.43 | — | — | $72.2M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $1.44 | — | — | $217.39M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.87 | — | — | $135.25M | Reported |
Consensus PT $14 · 1 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 01. 13. | Oppenheimer | — | Initiate coverage | — → Perform | — | Oppenheimer: Perform |
| 2024. 11. 13. | Raymond James | — | Maintain | Outperform → Outperform | — | Raymond James: Outperform |
| 2024. 01. 17. | Raymond James | — | Initiate coverage | — → Outperform | — | Raymond James: Outperform |